HK1211026A1 - Process for making thienopyrimidine compounds - Google Patents

Process for making thienopyrimidine compounds

Info

Publication number
HK1211026A1
HK1211026A1 HK15111757.3A HK15111757A HK1211026A1 HK 1211026 A1 HK1211026 A1 HK 1211026A1 HK 15111757 A HK15111757 A HK 15111757A HK 1211026 A1 HK1211026 A1 HK 1211026A1
Authority
HK
Hong Kong
Prior art keywords
making
thienopyrimidine compounds
thienopyrimidine
compounds
making thienopyrimidine
Prior art date
Application number
HK15111757.3A
Other languages
English (en)
Chinese (zh)
Inventor
Srinivasan Babu
Zhigang Cheng
Francis Gosselin
Pirmin Hidber
Ursula Hoffmann
Theresa Humphries
Reinhard Reents
Qingping Tian
Herbert Yajima
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1211026A1 publication Critical patent/HK1211026A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Health & Medical Sciences (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
HK15111757.3A 2012-10-10 2015-11-30 Process for making thienopyrimidine compounds HK1211026A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261711900P 2012-10-10 2012-10-10
PCT/EP2013/070994 WO2014056955A1 (en) 2012-10-10 2013-10-09 Process for making thienopyrimidine compounds

Publications (1)

Publication Number Publication Date
HK1211026A1 true HK1211026A1 (en) 2016-05-13

Family

ID=49322377

Family Applications (2)

Application Number Title Priority Date Filing Date
HK18103640.8A HK1244272A1 (zh) 2012-10-10 2015-11-30 製備噻吩並嘧啶化合物的方法
HK15111757.3A HK1211026A1 (en) 2012-10-10 2015-11-30 Process for making thienopyrimidine compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK18103640.8A HK1244272A1 (zh) 2012-10-10 2015-11-30 製備噻吩並嘧啶化合物的方法

Country Status (13)

Country Link
US (1) US8895729B2 (de)
EP (1) EP2906566B1 (de)
JP (1) JP6123097B2 (de)
KR (1) KR101698283B1 (de)
CN (2) CN104718212B (de)
AR (1) AR092960A1 (de)
BR (1) BR112015007970A8 (de)
CA (1) CA2883513A1 (de)
ES (1) ES2594078T3 (de)
HK (2) HK1244272A1 (de)
MX (1) MX349551B (de)
RU (1) RU2637309C2 (de)
WO (1) WO2014056955A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895729B2 (en) * 2012-10-10 2014-11-25 Genentech, Inc. Process for making thienopyrimidine compounds
AR096178A1 (es) * 2013-05-06 2015-12-09 Hoffmann La Roche Procedimiento para la preparacion de intermediarios de acido boronico.
WO2015116735A1 (en) 2014-01-28 2015-08-06 Mayo Foundation For Medical Education And Research Methods and combinations for killing senescent cells and for treating senescence-associated diseases and disorders
SG10201805670QA (en) 2014-01-28 2018-08-30 Buck Inst Res Aging Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201825465A (zh) 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
SG11201903723RA (en) * 2016-11-02 2019-05-30 Curis Inc Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety
WO2019180141A1 (en) 2018-03-23 2019-09-26 Bayer Aktiengesellschaft Combinations of rogaratinib
CN113717049A (zh) * 2021-08-05 2021-11-30 江西兄弟医药有限公司 一种制备（s）-乙酰氧基丙酰氯的半连续方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846824A (en) 1994-02-07 1998-12-08 Ludwig Institute For Cancer Research Polypeptides having kinase activity, their preparation and use
GB9208135D0 (en) 1992-04-13 1992-05-27 Ludwig Inst Cancer Res Polypeptides having kinase activity,their preparation and use
US6274327B1 (en) 1992-04-13 2001-08-14 Ludwig Institute For Cancer Research Polypeptides having kinase activity, their preparation and use
US6395916B1 (en) 1998-07-10 2002-05-28 Massachusetts Institute Of Technology Ligands for metals and improved metal-catalyzed processes based thereon
US6307087B1 (en) 1998-07-10 2001-10-23 Massachusetts Institute Of Technology Ligands for metals and improved metal-catalyzed processes based thereon
US7223879B2 (en) 1998-07-10 2007-05-29 Massachusetts Institute Of Technology Ligands for metals and improved metal-catalyzed processes based thereon
BR0211073A (pt) 2001-07-12 2004-12-14 Avecia Ltd Sistema de catalisador, e, processos para a preparação de um catalisador microencapsulado, de bifenilas opcionalmente substituìdas, de alcenos opcionalmente substituìdos, de um produto hidrogenado e de dióis
GB0423653D0 (en) 2004-10-25 2004-11-24 Piramed Ltd Pharmaceutical compounds
GB0608264D0 (en) * 2006-04-26 2006-06-07 Piramed Ltd Pharmaceutical compounds
TWI498332B (zh) 2006-04-26 2015-09-01 Hoffmann La Roche 作為pi3k抑制劑之嘧啶衍生物及相關製備方法、醫藥組合物、用途、套組及產物
CN101600720A (zh) * 2006-12-07 2009-12-09 霍夫曼-拉罗奇有限公司 磷酸肌醇3-激酶抑制剂化合物及使用方法
CL2007003523A1 (es) * 2006-12-07 2008-08-22 Piramed Ltd Genentech Inc Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad de pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso en el tratamiento profilactico o terapeutico del cancer
WO2008070740A1 (en) * 2006-12-07 2008-06-12 F.Hoffmann-La Roche Ag Phosphoinositide 3-kinase inhibitor compounds and methods of use
CL2008002687A1 (es) * 2007-09-12 2009-01-16 Genentech Inc Uso de una combinacion farmaceutica de un compuesto derivado de tieno[3,2-d]pirimidina con un agente quimioterapeutico en el tratamiento de un trastorno hiperproliferativo; kit farmaceutico.
US8354528B2 (en) 2007-10-25 2013-01-15 Genentech, Inc. Process for making thienopyrimidine compounds
CN101952298B (zh) 2007-12-12 2015-06-17 麻省理工学院 用于过渡金属催化的交联偶合反应的配体及其使用方法
MX2011009167A (es) 2009-03-12 2011-09-15 Genentech Inc Combinaciones de compuestos inhibidores de fosfoinositida 3-cinasa y agentes quimioterapeuticos para el tratamiento contra neoplasia hemotopoyeticas malignas.
WO2012164060A1 (en) 2011-06-03 2012-12-06 F. Hoffmann-La Roche Ag Methods of treating mesothelioma with a pi3k inhibitor compound
CN102399235A (zh) * 2011-10-25 2012-04-04 江苏弘和药物研发有限公司 一种2-氨基-5-嘧啶硼酸频哪醇酯的合成方法
CN102367260A (zh) * 2011-12-12 2012-03-07 南京药石药物研发有限公司 2-氨基嘧啶-5-硼酸的合成方法
CN102675323B (zh) * 2012-06-01 2014-04-09 南京药石药物研发有限公司 吡咯并[2,1-f][1,2,4]三嗪衍生物及其抗肿瘤用途
US8895729B2 (en) * 2012-10-10 2014-11-25 Genentech, Inc. Process for making thienopyrimidine compounds
CN102993163A (zh) * 2012-12-07 2013-03-27 青岛前线生物工程有限公司 3-甲基噻吩-2-甲醛的合成方法

Also Published As

Publication number Publication date
EP2906566A1 (de) 2015-08-19
AR092960A1 (es) 2015-05-06
US20140100366A1 (en) 2014-04-10
MX349551B (es) 2017-08-02
CN104718212A (zh) 2015-06-17
ES2594078T3 (es) 2016-12-15
EP2906566B1 (de) 2016-08-24
RU2637309C2 (ru) 2017-12-04
KR20150054945A (ko) 2015-05-20
WO2014056955A1 (en) 2014-04-17
JP6123097B2 (ja) 2017-05-10
CN107188898A (zh) 2017-09-22
KR101698283B1 (ko) 2017-01-19
CN107188898B (zh) 2019-12-03
CN104718212B (zh) 2017-06-16
HK1244272A1 (zh) 2018-08-03
RU2015113747A (ru) 2016-12-10
BR112015007970A2 (pt) 2017-07-04
CA2883513A1 (en) 2014-04-17
US8895729B2 (en) 2014-11-25
MX2015004467A (es) 2015-07-14
BR112015007970A8 (pt) 2019-08-27
JP2015534572A (ja) 2015-12-03

Similar Documents

Publication Publication Date Title
ZA201500664B (en) Process for making isoquinoline compounds
ZA201501866B (en) Production method for centre-pillar reinforcement
EP2867189A4 (de) Verfahren zur acrylatherstellung
EP2890672A4 (de) Neues verfahren
GB201223032D0 (en) Method for forming shaped preform
HK1244272A1 (zh) 製備噻吩並嘧啶化合物的方法
EP2814796A4 (de) Verfahren zur herstellung von tetrafluorpropen
HK1203933A1 (en) Thienopyrimidine compounds
HK1208673A1 (en) Process for making hydroxylated cyclopentylpyrimidine compounds
HK1208451A1 (en) Process for making hydroxylated cyclopentylpyrimidine compounds
EP2938814A4 (de) Verfahren zur herstellung von öl
EP2852660A4 (de) Verfahren
GB2488894B (en) Process for producing V-Coelenterazine compounds
HK1204607A1 (en) Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2- methyl-pentanoic acid compounds 4--5--4--2--2--
PL2914574T3 (pl) Nowy sposób
GB2523708B (en) Method for ion production
EP2855433A4 (de) Verfahren zur herstellung von dihalopyridinen
SG11201501831WA (en) Aminoethylation process for producing aryloxyalkylene amine compounds
EP2819995A4 (de) Verfahren zur herstellung von 3-methylsulfonylpropionitril
GB2524201B (en) Process for making confections
IL233433A (en) A process for making affluent
HUP1200614A2 (en) Process for development catalayzer
EP2831054A4 (de) Verbessertes verfahren zur herstellung von (s)-equol
GB201204381D0 (en) Novel process
GB201202098D0 (en) New process